Large‐Scale Proteomics Uncovers Pre‐Disease Inflammation–Lipid Subtypes to Refine Risk Stratification and Prediction of Type 2 Diabetes
Abstract
AIMS: Type 2 diabetes exhibits substantial heterogeneity prior to disease onset, posing challenges for early prevention. This study aimed to identify pre-disease subgroups with distinct risk profiles and develop subgroup-specific prediction models to facilitate early detection and precision intervention. MATERIALS AND METHODS: Proteomic data from 41 030 participants without diabetes at baseline in the UK Biobank were analysed. Proteins associated with incident type 2 diabetes were identified using multivariable-adjusted Cox regression and Least Absolute Shrinkage and Selection Operator (LASSO) regression. Finite Gaussian mixture model-based clustering was applied to define risk subgroups. Heterogeneity among subgroups was characterised according to proteomic patterns, clinical traits and disease risk. Subgroup-specific prediction models were subsequently developed using Cox regression. RESULTS: A total of 113 protein markers were identified, stratifying the population into three subgroups: metabolically healthy group (MHG), mild inflammation group (MIG) and Dyslipidemia with inflammation group (DLIG). Compared with MHG, DLIG showed the highest risk of type 2 diabetes (HR = 2.58, 95% CI: 2.34-2.84), followed by MIG (HR = 1.71, 95% CI: 1.49-1.98). Enrichment analysis indicated dysregulation of immune-inflammatory and lipid metabolism pathways in DLIG and MIG. Clinically, DLIG exhibited higher BMI, waist circumference, triglycerides, and C-reactive protein levels, whereas MIG showed moderately elevated C-reactive protein. Subgroup-specific proteomic models outperformed traditional clinical models in predicting diabetes risk (AUC 0.820-0.889 vs. 0.709-0.784; C-index 0.787-0.847 vs. 0.687-0.747). CONCLUSION: Proteomics-based clustering identified three pre-disease subtypes of type 2 diabetes characterized by inflammation-lipid profiles, improving risk prediction and supporting precision prevention.
Fields of Study & Subjects
Adipokines
Inflammation
and Metabolic Diseases
GDF15 and Related Biomarkers
Inflammatory Biomarkers in Disease Prognosis
Publication details
- Journal / source
- Diabetes Obesity and Metabolism
- Publisher
- Wiley
- Volume
- 28
- Issue
- 9
- Pages
- 8288–8298
- Publication date
- 22 June 2026
- Language
- EN